REGISTERED AND RENEWED
on 16 Oct 2024
Last Applicant/ Owned by
ONE AMGEN CENTER DRIVE
THOUSAND OAKS
CA
91320-1799
Serial Number
86109590 filed on 04th Nov 2013
Registration Number
4598910 registered on 02th Sep 2014
Correspondent Address
Elsa D. Lemoine
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
OTEZLA
Pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system; pharmaceutical preparations for the treatment of chronic inflammatory diseases, ankylosing spondylitis, psoriasis, psoriatic arthritis and cancer
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system; pharmaceutical preparations for the treatment of chronic inflammatory diseases, ankylosing spondylitis, psoriasis, psoriatic arthritis and cancer
First Use Date in General
21st Mar 2014
First Use Date in Commerce
21st Mar 2014
Mark Details
Serial Number
No 86109590
Mark Type
No Service/Collective Mark
Attorney Docket Number
No TM-2026-US-1
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Design Code(s)
01.15.13 -
Single wave of water
26.07.21 -
Diamonds that are completely or partially shaded
Legal History
| Status Date | Action Taken |
|---|---|
| 16th Oct 2024 | NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED |
| 16th Oct 2024 | REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) |
| 16th Oct 2024 | REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED |
| 16th Oct 2024 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| 23rd Jul 2024 | TEAS SECTION 8 & 9 RECEIVED |
| 02th Sep 2023 | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED |
| 19th Jun 2020 | REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED |
| 27th May 2020 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| 27th May 2020 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 27th May 2020 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |